Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2015First federal award
$10.3MFederal grants as PI12 awards
4Patents grantedLatest Apr 29, 2025
94Papers2,265 citations
Federal awards and patents by year
AwardsPatents
12 awards · $10.3M
| Date | Agency | Award | Amount | Company |
|---|---|---|---|---|
| May 13, 2026 | NIH | SBIR Phase II Rapid Test to Assist Therapy in Neonatal Sepsis and Necrotizing Enterocolitis | $954K | PROTHERA BIOLOGICS, INC. |
| Apr 25, 2025 | NIH | SBIR Phase II Rapid Test to Assist Therapy in Neonatal Sepsis and Necrotizing Enterocolitis | $971K | PROTHERA BIOLOGICS, INC. |
| Apr 25, 2025 | NIH | SBIR Phase I Inter-alpha Inhibitors in Experimental Necrotizing Enterocolitis | $50K | PROTHERA BIOLOGICS, INC. |
| Apr 18, 2024 | NIH | SBIR Phase II Rapid Test to Assist Therapy in Neonatal Sepsis and Necrotizing Enterocolitis | $987K | PROTHERA BIOLOGICS, INC. |
| Sep 22, 2023 | NIH | SBIR Phase I Inter-alpha Inhibitors in Experimental Necrotizing Enterocolitis | $378K | PROTHERA BIOLOGICS, INC. |
| Sep 7, 2023 | NIH | SBIR Phase II Inter-alpha Inhibitors in Hypoxic-Ischemic Brain Injury | $2.8M | PROTHERA BIOLOGICS, INC. |
| Mar 27, 2020 | NIH | SBIR Phase II Rapid Test to Assist Therapy in Neonatal Sepsis and Necrotizing Enterocolitis | $862K | PROTHERA BIOLOGICS, INC. |
| May 3, 2019 | NIH | SBIR Phase II Rapid Test to Assist Therapy in Neonatal Sepsis and Necrotizing Enterocolitis | $1.0M | PROTHERA BIOLOGICS, INC. |
| Aug 14, 2018 | NIH | SBIR Phase II Rapid Test to Assist Therapy in Neonatal Sepsis and Necrotizing Enterocolitis | $167K | PROTHERA BIOLOGICS, INC. |
| Jun 15, 2018 | NIH | SBIR Phase II Inter-alpha Inhibitors in Hypoxic-Ischemic Brain Injury | $941K | PROTHERA BIOLOGICS, INC. |
| Jun 9, 2017 | NIH | SBIR Phase II Inter-alpha Inhibitors in Hypoxic-Ischemic Brain Injury | $984K | PROTHERA BIOLOGICS, INC. |
| Sep 16, 2015 | NIH | SBIR Phase I Therapeutic Role of Inter-alpha Inhibitors in Wound Healing | $225K | PROTHERA BIOLOGICS, INC. |
5 patents as inventor
- US 10076559PROTHERA BIOLOGICS, INC.Sep 18, 2018
- US 12265090PROTHERA BIOLOGICS, INC.Apr 1, 2025
- US 12285471PROTHERA BIOLOGICS, INC.Apr 29, 2025
- US 9758570PROTHERA BIOLOGICS, INC.Sep 12, 2017
- US PROTHERA BIOLOGICS, INC.—
Matched by the first inventor’s name and the patent’s company.
Peer ranks
Federal funding#58
Awards as PI#86
Patents#41
Companies
- PROTHERA BIOLOGICS, INC.Linked by awards · Biotech
Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.